JPET Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 18, 2005; DOI: 10.1124/jpet.105.083253


0022-3565/05/3133-1194-1202$20.00
JPET 313:1194-1202, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.083253v1
313/3/1194    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, M. E.
Right arrow Articles by Wang, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, M. E.
Right arrow Articles by Wang, Q.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Renal Clearance of {gamma}-Hydroxybutyric Acid in Rats: Increasing Renal Elimination as a Detoxification Strategy

Marilyn E. Morris, Ke Hu1, and Qi Wang

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, New York

Intoxication with {gamma}-hydroxybutyric acid (GHB) is associated with coma, seizure, and death; treatment of overdoses is symptomatic. The objectives of this investigation were to characterize the renal clearance and total clearance of GHB in rats and to evaluate potential strategies for increasing the elimination of GHB after drug overdoses. GHB was administered by i.v. infusion at low (108 mg/h/kg), medium (128 mg/h/kg), or high (208 mg/h/kg) doses. Crossover studies were performed under steady-state conditions using the medium dose in the absence or presence of L-lactate, pyruvate, D-mannitol, sodium bicarbonate, or normal saline. GHB in plasma and urine samples was assayed using liquid chromatography-tandem mass spectrometry. Infusion of the low, medium, and high doses of GHB produced steady-state plasma concentrations of 0.22 ± 0.04, 0.43 ± 0.05, and 0.68 ± 0.11 mg/ml. The renal clearance of the medium (51.8 ± 13.0 ml/h/kg) and high (97.1 ± 43.1 ml/h/kg) doses was significantly higher than that of the low dose (14.9 ± 5.1 ml/h/kg), whereas the total clearance values were significantly lower than that of the low dose. The renal clearance was significantly increased by the concomitant administration of L-lactate, pyruvate, D-mannitol, or sodium bicarbonate with GHB but was not altered by normal saline. The total and metabolic clearance values were significantly increased by all treatments except normal saline. Overall, our results indicated that the renal clearance of GHB is dose-dependent, involving capacity-limited reabsorption. Monocarboxylate transport inhibitors, osmotic diuresis using D-mannitol, or the administration of sodium bicarbonate can increase the renal and total clearances of GHB. The approaches used in this investigation may offer potential detoxification strategies for the treatment of GHB overdoses.


Received January 7, 2005; accepted February 17, 2005.

Address correspondence to: Dr. Marilyn E. Morris, 517 Hochstetter Hall, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, NY 14260. E-mail: memorris{at}buffalo.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Q. Wang and M. E. Morris
The Role of Monocarboxylate Transporter 2 and 4 in the Transport of {gamma}-Hydroxybutyric Acid in Mammalian Cells
Drug Metab. Dispos., August 1, 2007; 35(8): 1393 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Wang and M. E. Morris
Flavonoids Modulate Monocarboxylate Transporter-1-Mediated Transport of {gamma}-Hydroxybutyrate in Vitro and in Vivo
Drug Metab. Dispos., February 1, 2007; 35(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Wang, I. M. Darling, and M. E. Morris
Transport of {gamma}-Hydroxybutyrate in Rat Kidney Membrane Vesicles: Role of Monocarboxylate Transporters
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 751 - 761.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.